Why the study?
Does the MMP3 5A/6A polymorphism increase the risk of acute myocardial infarction in patients with atherosclerosis?
Does the MMP3 5A/6A polymorphism increase the risk of acute myocardial infarction in patients with atherosclerosis?
The MMP3 5A allele is associated with an increased risk of acute myocardial infarction, supporting the hypothesis that increased matrix metalloproteinase activity contributes to atherosclerotic plaque destabilization and rupture.
MMP3 5A association with AMI is hypothesis-generating; leaves open clinical utility pending prospective validation.
Current evidence suggests that matrix metalloproteinases (MMPs) have a role in early atherosclerosis, plaque rupture and myocardial infarction. Polymorphisms in MMP genes have been examined for associations with atherosclerosis, but interpretation is complicated by methodological issues. This article presents a systematic review of these association studies and a meta-analysis of available data for polymorphisms where a sufficient number of studies was available. The 5A allele of the MMP3 5A/6A polymorphism was associated with acute myocardial infarction (odds ratio (OR) 1.26, 95% confidence interval (CI) 1.1 to 1.4, p<0.001), suggesting its role in plaque rupture. There was no association with the functional MMP9 -1562C/T polymorphism (OR 1.11, 95% CI 1.0 to 1.3, p = 0.18). Current data provide evidence for the role of MMP3 polymorphism in plaque destabilisation, but elucidation of the role of other MMP gene variants in atherosclerosis will depend on better study design, including a larger sample size, extensive screening of individual genes with haplotype analysis and replication of studies to avoid publication bias.
No takes yet. Share an insight, caveat, or question.
Abilleira et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: